← Browse by Condition

Medical Condition

crohn disease

Total Trials

19

Recruiting Now

19

Trial Phases

Phase 4, Phase 2, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for crohn disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — crohn disease Clinical Trials

How many clinical trials are currently recruiting for crohn disease?

ClinicalMetric currently tracks 19 actively recruiting clinical trials for crohn disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 19. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for crohn disease?

crohn disease research spans Phase 1 (2 trials), Phase 2 (3 trials), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a crohn disease clinical trial?

Eligibility criteria for crohn disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

2

Phase 2

3

Phase 4

2

Top Sponsors

Massachusetts General Hospital 2 trials

Yuki Horio 1 trial

Centre Hospitalier Universitaire de Nīmes 1 trial

Catholic University of the Sacred Heart 1 trial

University Hospital Tuebingen 1 trial

Recruiting Clinical Trials

A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

Massachusetts General Hospital

NCT07872449 Phase 4

Risankizumab for Refractory Perianal Fistulizing Crohn's Disease

Safety of Mesentery-embedding Surgery in Patients With Ileocolic Crohn's Disease on Biotherapy

Centre Hospitalier Universitai...

A Specific Probiotic in thE MOdulation of Gut Microbiota of patieNts With Mild-to-modErate Ulcerative Colitis

Catholic University of the Sac...

NCT06953791 Phase 2

Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Patients

University Hospital Tuebingen

Decoding the Clinical Impact of Host and Microbial Intestinal Proteomic Landscape in Crohn's Disease

Germany, Israel

Weizmann Institute of Science

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

Massachusetts General Hospital

Gut Microbiome in Inflammatory Bowel Disease

Kyunghee University Medical Ce...

The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.

University Hospital, Clermont-...

A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial

Anterogen Co., Ltd.

NCT04970446 Phase 1, Phase 2

Microbial Restoration in Inflammatory Bowel Diseases

St Vincent's Hospital Melbourn...

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

Second Affiliated Hospital, Zh...

NCT04924270 Phase 2

Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases

Odense University Hospital

NCT05169593 Phase 4

Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy

Universitaire Ziekenhuizen KU ...

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Fecal Microbiota Transplantation in Pediatric Crohn's Disease

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

Boston Children's Hospital

Therapeutic Endpoint in Pediatric IBD Conditions

Children's National Research I...

NCT03816345 Phase 1

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

United States, Canad...

National Cancer Institute (NCI...

Related Conditions

ulcerative colitis (6) inflammatory bowel diseases (5) rheumatoid arthritis (3) healthy (2) multiple sclerosis (2) psoriatic arthritis (2) inflammatory bowel disease (2) lynch syndrome (1) perianal fistula (1) perianal fistula due to crohn s disease (1) perianal crohn s disease (1) nutrition assessment (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology